Vanguard Group’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.76M | Sell |
1,943,285
-3,224
| -0.2% | -$14.5K | ﹤0.01% | 2975 |
|
|
2025
Q1 | $8.62M | Sell |
1,946,509
-53,513
| -3% | -$237K | ﹤0.01% | 2925 |
|
|
2024
Q4 | $15.7M | Sell |
2,000,022
-35,341
| -2% | -$277K | ﹤0.01% | 2707 |
|
|
2024
Q3 | $26.8M | Buy |
2,035,363
+78,024
| +4% | +$1.03M | ﹤0.01% | 2453 |
|
|
2024
Q2 | $23.6M | Sell |
1,957,339
-112,178
| -5% | -$1.36M | ﹤0.01% | 2484 |
|
|
2024
Q1 | $33.7M | Sell |
2,069,517
-174,721
| -8% | -$2.84M | ﹤0.01% | 2344 |
|
|
2023
Q4 | $15.3M | Buy |
2,244,238
+12,330
| +0.6% | +$84.1K | ﹤0.01% | 2714 |
|
|
2023
Q3 | $12.2M | Buy |
2,231,908
+4,899
| +0.2% | +$26.7K | ﹤0.01% | 2771 |
|
|
2023
Q2 | $15.1M | Sell |
2,227,009
-53,993
| -2% | -$367K | ﹤0.01% | 2714 |
|
|
2023
Q1 | $11.4M | Buy |
2,281,002
+22,748
| +1% | +$114K | ﹤0.01% | 2868 |
|
|
2022
Q4 | $11M | Buy |
2,258,254
+337,833
| +18% | +$1.65M | ﹤0.01% | 2913 |
|
|
2022
Q3 | $27.7M | Sell |
1,920,421
-9,495
| -0.5% | -$137K | ﹤0.01% | 2483 |
|
|
2022
Q2 | $29.2M | Buy |
1,929,916
+135,406
| +8% | +$2.05M | ﹤0.01% | 2457 |
|
|
2022
Q1 | $21.3M | Sell |
1,794,510
-22,564
| -1% | -$268K | ﹤0.01% | 2737 |
|
|
2021
Q4 | $29.5M | Buy |
1,817,074
+13,150
| +0.7% | +$213K | ﹤0.01% | 2639 |
|
|
2021
Q3 | $51.5M | Buy |
1,803,924
+168,669
| +10% | +$4.81M | ﹤0.01% | 2348 |
|
|
2021
Q2 | $55.3M | Buy |
1,635,255
+36,676
| +2% | +$1.24M | ﹤0.01% | 2315 |
|
|
2021
Q1 | $48.3M | Buy |
1,598,579
+117,546
| +8% | +$3.55M | ﹤0.01% | 2336 |
|
|
2020
Q4 | $73.3M | Buy |
1,481,033
+236,743
| +19% | +$11.7M | ﹤0.01% | 1998 |
|
|
2020
Q3 | $47.8M | Buy |
1,244,290
+4,626
| +0.4% | +$178K | ﹤0.01% | 2036 |
|
|
2020
Q2 | $53.6M | Buy |
1,239,664
+158,006
| +15% | +$6.83M | ﹤0.01% | 1980 |
|
|
2020
Q1 | $28.2M | Buy |
1,081,658
+26,461
| +3% | +$691K | ﹤0.01% | 2128 |
|
|
2019
Q4 | $33M | Buy |
1,055,197
+312,215
| +42% | +$9.76M | ﹤0.01% | 2301 |
|
|
2019
Q3 | $19.4M | Buy |
742,982
+253,400
| +52% | +$6.6M | ﹤0.01% | 2504 |
|
|
2019
Q2 | $11.2M | Buy |
489,582
+205,021
| +72% | +$4.69M | ﹤0.01% | 2796 |
|
|
2019
Q1 | $7.46M | Buy |
284,561
+27,296
| +11% | +$715K | ﹤0.01% | 2978 |
|
|
2018
Q4 | $5.23M | Buy |
257,265
+172,165
| +202% | +$3.5M | ﹤0.01% | 3071 |
|
|
2018
Q3 | $2.26M | Buy |
+85,100
| New | +$2.26M | ﹤0.01% | 3487 |
|